View Document Preview and Link Document Date: 2014-05-20 20:49:15 Open Document File Size: 655,04 KB Share Result on Facebook
Company Melatonin Reclassification Application Aspen Pharma Pty Limited / CVS / Aspen Pharma Pty Limited / / Continent Europe / / Country United States / Canada / Australia / United Kingdom / New Zealand / / Event FDA Phase / / Facility Pharmacy Guild / Pharmacy Today / Pharmacy Retailing / / IndustryTerm short screening tool / age / cough-cold products / immediate release product / manufacturing quality / registered products / / MedicalCondition insomnia / Alzheimer’s disease / hypertension / change Insomnia / cognitive impairment / primary insomnia / Many insomnia / psychiatric disorders / secondary insomnia / drowsiness / chronic benzodiazepine / occasional sleeplessness / chronic hypnotic drugs consumption33 / chronic insomnia / sleep disorders / depression / primary sleep disorders / influenza / chronic conditions / had training in sleep disorders / / MedicalTreatment dietary supplement / Cognitive behavioural therapy / behavioural therapy / Home remedies / / Organization Pharmaceutical Society of NZ / College of Pharmacists / Health Canada Natural Health Products Directorate / Pharmacy Council / European Union / Pharmacy Guild of NZ / / Position pharmacist / general sales classification statement / / Product 5mg / CIRCADIN tablets / Tricyclic / For oral / for / NZ / CIRCADIN / / PublishedMedium the Best Practice Journal / / Technology GPS / / SocialTag 
Melatonin Reclassification Application Aspen Pharma Pty Limited July 2012 Application to Reclassify Melatonin in NZ, July 2012